Top U.S. states by financial penalties for pharmaceutical companies 1991-2015

This statistic represents top US states based on financial penalties for pharmaceutical companies between 1991 and 2015. In that period, Louisiana claimed some 300 million U.S. dollars through penalties from pharmaceutical companies.

Top U.S. states based on financial penalties for pharmaceutical companies between 1991 and 2015 (in million U.S. dollars)*

Penalties in million U.S. dollars
Texas690.1
Louisiana300.6
California210.3
Pennsylvania189.9
South Carolina169
Kentucky147.3
Alabama124.3
Mississippi106.5
Hawaii83.8
Florida75.8
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

March 2016

Region

United States

Survey time period

1991 to 2015

Supplementary notes

* From single-state and multi-state settlements between state governments and pharmaceutical manufacturers.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.